These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18724156)

  • 1. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.
    Sosa AB; Epstein SP; Asbell PA
    Cornea; 2008 Sep; 27(8):930-4. PubMed ID: 18724156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines.
    Ayaki M; Iwasawa A; Niwano Y
    Biocontrol Sci; 2012 Jun; 17(2):93-9. PubMed ID: 22790846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells.
    Epstein SP; Ahdoot M; Marcus E; Asbell PA
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):113-9. PubMed ID: 19284328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fluoroquinolone eye solutions without preservatives on human corneal epithelial cells in vitro.
    Oum BS; Kim NM; Lee JS; Park YM
    Ophthalmic Res; 2014; 51(4):216-23. PubMed ID: 24732570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.
    Kim SY; Lim JA; Choi JS; Choi EC; Joo CK
    Cornea; 2007 Jul; 26(6):720-5. PubMed ID: 17592324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.
    Miyake T; Ito N; Tajima K; Goto H; Furukawa T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1035-41. PubMed ID: 22282216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.
    Ly LT; Cavanagh HD; Petroll WM
    Eye Contact Lens; 2006 Jul; 32(4):161-5. PubMed ID: 16845259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
    Tsai TH; Chen WL; Hu FR
    Eye (Lond); 2010 May; 24(5):909-17. PubMed ID: 19648900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.
    Bezwada P; Clark LA; Schneider S
    Curr Med Res Opin; 2008 Feb; 24(2):419-24. PubMed ID: 18157922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro.
    Papa V; Leonardi A; Getuli C; Pacelli V; Russo P; Milazzo G
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):535-45. PubMed ID: 14733711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fluoroquinolone-Based Antibacterial Ophthalmic Solutions on Corneal Wound Healing.
    Fukuda M; Sasaki H
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):536-40. PubMed ID: 26186125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E; Perry HD; Chruscicki DA; Bitterman A; Cohn S; Solomon R
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of moxifloxacin as shown in animal and in vitro studies.
    McGee DH; Holt WF; Kastner PR; Rice RL
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti-infective ophthalmic solutions on corneal cells in vitro.
    Matsumoto S; Stern ME
    Adv Ther; 2000; 17(3):148-51. PubMed ID: 11183451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.
    Ayaki M; Yaguchi S; Iwasawa A; Koide R
    Clin Exp Ophthalmol; 2008 Aug; 36(6):553-9. PubMed ID: 18954319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.
    Price MO; Price FW; Maclellan D
    J Cataract Refract Surg; 2005 Nov; 31(11):2137-41. PubMed ID: 16412928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
    Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy.
    Kovoor TA; Kim AS; McCulley JP; Cavanagh HD; Jester JV; Bugde AC; Petroll WM
    Eye Contact Lens; 2004 Apr; 30(2):90-4. PubMed ID: 15260356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.
    Reviglio VE; Hakim MA; Song JK; O'Brien TP
    BMC Ophthalmol; 2003 Oct; 3():10. PubMed ID: 14529574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].
    Kernt M; Hirneiss C; Neubauer AS; Liegl RG; Eibl KH; Wolf A; de Kaspar H; Ulbig MW; Kampik A
    Ophthalmologe; 2010 Aug; 107(8):720-7. PubMed ID: 19756636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.